2024 Bulgaria Blood Typing, Grouping and Infectious Disease NAT Screening Market--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget.The database from LeadingMarketResearch.com provides the 2023 supplier shares and strategies, the 2023-2028 volume and sales forecasts for over 40 immunohematology and NAT assays, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NATThe companies analyzed in the report include:
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NATThe companies analyzed in the report include:
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Proteome Sciences
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher
More Publications
2024 Bulgaria Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 2,850.00
July 2020
1120 pages
2024 Bulgaria Diagnostics Market Shares and Forecasts for 500 Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,500.00
June 2020
40 pages
Bulgaria Tumor Marker Testing Market, 2019-2023:: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Tests, Technologies and Opportunities
US$ 3,850.00
May 2019
535 pages
